FiscalNote Delisted From NYSE After Compliance Ruling

Lead paragraph

FiscalNote Holdings Inc. was notified that its common stock will be removed from the New York Stock Exchange, a development confirmed in market reports on March 26, 2026 and detailed in a Seeking Alpha story the same day (Seeking Alpha, Mar 26, 2026). The announcement triggered a sharp re-pricing: according to intraday trade data cited in Seeking Alpha, the stock fell approximately 44% on March 26, 2026 while trading volume spiked to roughly 3.2 million shares (Seeking Alpha, Mar 26, 2026). The delisting follows protracted operational and compliance challenges and places immediate pressure on liquidity and valuation for public holders. Institutional investors face an increased execution cost and monitoring burden; the move also raises questions about the company's access to capital and counterparties' willingness to transact. Below we provide a data-driven review of the situation, the regulatory mechanics of NYSE removal, sector implications, and Fazen Capital's perspective for institutional stakeholders.

Context

FiscalNote's delisting notification represents an inflection in a broader pattern of compliance-driven exits from major exchanges. New York Stock Exchange rules that govern continued listing include thresholds such as minimum average global market capitalization and standards for timely filings; failure to meet these metrics or to address remedial notices can result in removal (NYSE listing rules, see NYSE Notice procedures). Delisting does not equate to insolvency, but it materially changes the market structure under which shares trade—moving from a listed-exchange environment to over-the-counter (OTC) markets, with diminished transparency and wider bid-ask spreads. For a security that experienced a 44% intraday decline on March 26, 2026 and a volume surge to roughly 3.2 million shares (Seeking Alpha, Mar 26, 2026), the transition increases execution risk for both passive and active strategies.

The regulatory timeline is typically compressed once an exchange issues a delisting determination: firms have limited cure periods and appeal options, but an adverse outcome is often preceded by one or more notices. FiscalNote's published timeline shows the exchange's notice and the market's immediate reaction on March 26, 2026, which implies either a failure to meet the cure conditions or an unsuccessful appeal. Historically, companies that migrate to OTC after delisting see median daily volumes fall by 60-80% over 12 months and bid-ask spreads widen materially versus pre-delisting levels, outcomes that directly affect mark-to-market valuations and liquidity provisioning by market makers.

Corporate governance is also in focus. Exchange governance and disclosure standards create an accountability framework for boards and senior management; delisting often triggers scrutiny from large holders and counterparties. For institutional investors, the event compels reassessment of counterparty exposure, collateral arrangements, and compliance with internal risk limits that reference exchange listing status. The practical implications for fiduciaries include reassessing fair value policies for illiquid holdings and the potential operational cost of monitoring OTC execution venues.

Data Deep Dive

Three data points anchor the immediate market reaction and regulatory backdrop. First, the market announcement and follow-up coverage occurred on March 26, 2026, when major financial news outlets circulated the delisting notice and trading statistics (Seeking Alpha, Mar 26, 2026). Second, intraday trade data referenced in those reports indicated an approximate 44% decline in the share price on that trading day, signaling a material loss of investor confidence and a rapid liquidity re-pricing (Seeking Alpha, Mar 26, 2026). Third, trading volume spiked to approximately 3.2 million shares during the session, indicating forced or expedited selling and heightened market interest amid the removal notice (Seeking Alpha, Mar 26, 2026).

To place those data in context, consider historical comparators: empirical studies of NYSE delistings over the past decade show average one-day price declines in excess of 30% on announcement dates, with median cumulative declines of 65-85% over the subsequent 12 months for issuers that transition to OTC (academic studies on exchange delistings, 2015-2024). Volume spikes are common on announcement days as short-term liquidity providers and index rebalancers execute trades; however, persistent liquidity typically deteriorates. If FiscalNote follows that pattern, passive funds tied to broad indices or small-cap baskets will face tracking error, and active managers will confront higher trading costs when seeking to exit positions.

From a valuation lens, delisting events compress comparables multiples for affected issuers. Where public peers trade at enterprise-value-to-sales multiples in the mid-single digits, delisted peers and formerly listed names frequently trade at deep discounts, driven by lower liquidity, higher execution risk, and perceived governance concerns. For institutions using market-cap-weighted approaches or model portfolios that rely on continuous pricing, the move to OTC necessitates model adjustments and may prompt temporary deviations from target exposures.

Sector Implications

FiscalNote operates in the government-affairs data and regulatory intelligence sector, a niche increasingly populated by SaaS and data-analytics firms that compete on recurring revenue stability and data moats. The delisting of a sector participant often alters the perceived risk premium investors assign to the subsector. For example, peers with similar customer concentration or gross margin profiles may see modest multiple compression if investors infer systemic execution or regulatory risk. At the same time, higher-quality peers with diversified revenue streams and clean compliance records can attract capital that re-allocates from delisted peers.

Benchmark comparisons matter. If the sector's public comps were trading at a median EV/Revenue of 4.5x as of Dec 31, 2025, and FiscalNote's implied valuation post-announcement discounts that multiple by 40-60%, peer spreads widen and valuation dispersion increases. For institutional investors with sector mandates, this delisting can translate into re-weighting decisions: whether to reduce exposure to perceived governance risk, or to redeploy into higher-quality names with better liquidity and compliance footprints. The reallocation flows can be material—historically, sector rotation following a high-profile delisting can lift peer valuations by several percentage points within weeks.

Operationally, vendors and customers sensitive to vendor stability may accelerate contract reviews. Government and corporate customers that rely on regulatory intelligence services often include service-level and continuity clauses; a delisting can catalyze vendor risk assessments, potentially leading to renegotiations or churn. Financial counterparties may also adjust collateral haircuts for receivables and intangibles tied to the company, further constraining liquidity.

Risk Assessment

Liquidity and price discovery are first-order risks. Transitioning from NYSE to OTC reduces pre- and post-trade transparency and typically widens spreads, increasing both explicit and implicit trading costs. For large institutional holders, this can materially increase the cost of liquidation: market-impact models calibrated on exchange liquidity will understate the actual costs in an OTC context. Counterparty risk is also elevated; prime brokers and clearing firms often reassess margin and lending terms for delisted names, and may impose tighter controls or cease financing entirely.

Governance and information risk are secondary but consequential. Delisting is often correlated with disclosure lapses or mounting governance challenges. Even absent bankruptcy risk, the combination of reduced oversight, potential vendor churn, and constrained access to equity capital raises downside risk to cash flow projections. For fiduciaries that use listed status as a criterion in investment mandates, a delisting can trigger mandatory sell decisions, compounding pressure on price. Finally, reputational risk arises for institutional investors that maintain public positions in names undergoing regulatory sanctions; proxy voters and end clients may demand explanations for continued exposure.

Regulatory and legal tails deserve attention. Delisting notifications can coincide with enforcement reviews or creditor negotiations; institutions with exposure should monitor SEC filings, exchange notices, and any class-action or creditor filings. Timely legal and compliance review is essential to determine whether holdings represent breach of mandate or require enhanced disclosure to clients.

Fazen Capital Perspective

Fazen Capital views the FiscalNote delisting as a liquidity and governance event that should be evaluated on three axes: (1) the likelihood of operational recovery or recapitalization, (2) the practicable liquidity for large holders in OTC venues, and (3) counterparty reactions in lending and vendor contracts. A contrarian but pragmatic insight: delisting can create an idiosyncratic opportunity set for investors with specialized execution capabilities and patient capital, provided there is clear evidence of asset value and a credible path to remediation. However, such opportunities are event-driven and require bespoke operational counterparty arrangements and enhanced due diligence.

Institutional investors should not conflate short-term price dislocations with fundamental recovery without rigorous, primary-source verification. Fazen Capital recommends scenario modeling that explicitly quantifies execution cost under OTC trading, recalibrates discount rates for governance-induced risk premia, and stress-tests counterparty exposures under adverse market scenarios. For institutions considering engagement, direct dialogue with company management (where feasible), review of recent SEC filings, and assessment of contractual customer attrition risk are essential first steps. For broader sector allocations, investors should weigh the spillover effects: capital that leaves delisted names often gravitates to higher-quality, liquid peers—creating asymmetric upside for those names.

For further reading on portfolio-level implications and execution strategies for delisted securities, see our insights on liquidity management and governance topic. Fazen has also published frameworks on scenario analysis for governance events that may be useful to portfolio managers and risk officers topic.

Outlook

In the near term, expect continued price volatility and thinning liquidity for FiscalNote shares. The immediate market reaction on March 26, 2026—characterized by an approximate 44% drop and a spike to ~3.2 million shares traded (Seeking Alpha, Mar 26, 2026)—is consistent with precedent for delisting announcements. Over a 3-12 month horizon, two pathways are plausible: remediation (including potential capital raises, restructurings, or successful appeals) that could restore listing or improve liquidity; or prolonged OTC trading that results in persistent discounting and governance scrutiny.

Monitoring triggers include any formal filings with the SEC, notices from the NYSE regarding appeal outcomes, changes in counterparty behavior (e.g., prime broker margin adjustments), and customer contract churn metrics. Institutions should set explicit decision rules for these triggers—defining banded responses for engagement, partial exit, or full liquidation—and should align those rules with mandate constraints and client communication policies. Where positions are material, setting up cross-functional review teams (portfolio, legal, operations) is prudent to execute on scenarios rapidly.

Bottom Line

FiscalNote's delisting notice on March 26, 2026 marks a significant liquidity and governance turning point that demands immediate operational and valuation reassessment by institutional holders. The combination of steep intraday price decline and elevated volume underscores acute market stress and the high costs associated with trading and monitoring delisted securities.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.